Literature DB >> 6334855

Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes.

D M Kranz, S Tonegawa, H N Eisen.   

Abstract

The molecular basis for the dependence of antigen recognition by T cells on products of the major histocompatibility complex (MHC) is unknown, and the antigenic structures that are actually bound by T-cell receptors are ill-defined. In this study, we asked whether a monoclonal antibody (mAb) that reacts with the T-cell receptor of a clone of murine cytotoxic T lymphocytes (CTL) and not with the receptors of other CTL clones can substitute for that clone's natural ligand in specific cytolytic reactions. To answer the question, a mAb (1B2) to the receptor of a CTL clone (2C) was attached covalently to 51Cr-labeled cells that were not otherwise susceptible to lysis by clone 2C, and the cells thus modified were then tested as targets for clone 2C and other CTL clones of similar specificity. All labeled cells modified in this way, including a murine cell line that expresses no cell-surface MHC class I molecules and a human cell line, were lysed by clone 2C but not by other CTL clones. If, however, instead of attaching the mAb to the receptor of clone 2C, the cells were modified by attaching to them mAbs to other surface antigens on CTL [lymphocyte function-associated antigen (LFA-1), Thy-1.2], they were not lysed. In cytolytic titrations, the cells that had been converted by attachment of mAb 1B2 into specific targets for clone 2C were just as susceptible to lysis by that clone as the clone's natural H-2d targets (e.g., P815 cells). However, some accessory surface molecules (LFA-1, Lyt-2) that are required for clone 2C to lyse its natural H-2d targets seemed not to be required for this clone to lyse the mAb-converted target cells. By demonstrating that a variety of different cell types can be thus converted into target cells for CTL, the approach described in this study may provide opportunities to analyze further the mechanisms by which CTL destroy target cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6334855      PMCID: PMC392265          DOI: 10.1073/pnas.81.24.7922

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Inhibition of cytotoxic T lymphocyte activity by concanavalin A.

Authors:  M V Sitkovsky; M S Pasternack; H N Eisen
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

3.  Monoclonal antibodies specific for a murine cytotoxic T-lymphocyte clone.

Authors:  U D Staerz; M S Pasternack; J R Klein; J D Benedetto; M J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

4.  Immunoprecipitation of cell surface structures of cloned cytotoxic T lymphocytes by clone-specific antisera.

Authors:  D M Kranz; D H Sherman; M V Sitkovsky; M S Pasternack; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

5.  Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor.

Authors:  S C Meuer; O Acuto; R E Hussey; J C Hodgdon; K A Fitzgerald; S F Schlossman; E L Reinherz
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

6.  Lymphocyte function-associated antigen 1 (LFA-1): a surface antigen distinct from Lyt-2,3 that participates in T lymphocyte-mediated killing.

Authors:  D Davignon; E Martz; T Reynolds; K Kürzinger; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

7.  Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes: analysis by antibody blocking and selective trypsinization.

Authors:  H R MacDonald; A L Glasebrook; J C Cerottini
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

8.  Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells.

Authors:  J Kaye; S Porcelli; J Tite; B Jones; C A Janeway
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

9.  The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody.

Authors:  K Haskins; R Kubo; J White; M Pigeon; J Kappler; P Marrack
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

10.  Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex.

Authors:  S C Meuer; K A Fitzgerald; R E Hussey; J C Hodgdon; S F Schlossman; E L Reinherz
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  52 in total

1.  Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65).

Authors:  R Holtappels; J Podlech; N K Grzimek; D Thomas; M F Pahl-Seibert; M J Reddehase
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs.

Authors:  R Holtappels; M F Pahl-Seibert; D Thomas; M J Reddehase
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Identification of an evolutionarily conserved, function-associated molecule on human natural killer cells.

Authors:  D T Harris; L Jaso-Friedmann; R B Devlin; H S Koren; D L Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions.

Authors:  Ronjon Chakraverty; Hyeon-Seok Eom; Jessica Sachs; Jennifer Buchli; Pete Cotter; Richard Hsu; Guiling Zhao; Megan Sykes
Journal:  Blood       Date:  2006-06-06       Impact factor: 22.113

5.  Characterization of a single-chain T-cell receptor expressed in Escherichia coli.

Authors:  W F Hoo; M J Lacy; L K Denzin; E W Voss; K D Hardman; D M Kranz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

6.  Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains.

Authors:  D H Aggen; A S Chervin; T M Schmitt; B Engels; J D Stone; S A Richman; K H Piepenbrink; B M Baker; P D Greenberg; H Schreiber; D M Kranz
Journal:  Gene Ther       Date:  2011-07-14       Impact factor: 5.250

7.  Regulation of clonal growth by anti-T-cell receptor antibody-directed lysis.

Authors:  P De Berardinis; M Londei; S Carrel; M Feldmann
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

8.  Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.

Authors:  U D Staerz; M J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

9.  Requirements for activation of CD8+ murine T cells. I. Development of cytolytic activity.

Authors:  D C Cronin; D W Lancki; F W Fitch
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

10.  Engineering higher affinity T cell receptors using a T cell display system.

Authors:  Adam S Chervin; David H Aggen; John M Raseman; David M Kranz
Journal:  J Immunol Methods       Date:  2008-10-12       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.